• Merimepodib (VX-497): What the PEDV Evidence Shows

  2026-10-07

  A source-grounded overview of how IMPDH biology may shape PEDV replication, what the available Merimepodib evidence demonstrates, and where interpretation remains limited by cell models, pharmacology, and the absence of clinical or animal efficacy data.

• KCR Optogenetics for Noninvasive Seizure Suppression

  2026-10-07

  Duan and colleagues developed HcKCR1-hs, a highly light-sensitive, moderately K⁺-selective channelrhodopsin designed to inhibit neuronal hyperexcitability through transcranial illumination. In several mouse status epilepticus models, activating the engineered channel delayed seizure onset, improved survival, and reduced seizure activity, providing preclinical evidence for a potassium-conductance strategy while leaving important translational questions unresolved.

• E-64 and Lysoptosis: From Protease Activity to Translation

  2026-10-06

  E-64 offers a mechanistically informative lens for studying cysteine protease activity, but its broad, irreversible target engagement must be interpreted alongside genetic and compartment-specific evidence. In the context of lysoptosis, it is best positioned as a translational research probe rather than a stand-alone therapeutic surrogate.

• How Netarsudil Enables Predictive siRNA Codelivery

  2026-10-06

  Slaughter and colleagues developed a quantitative framework linking ionizable-drug structure to siRNA complexation and nanoparticle encapsulation. Netarsudil, or AR-13324, served as a prospective test case, supporting codelivery of CTGF-targeting siRNA in fibrotic human trabecular meshwork cells, although the findings remain preclinical and formulation-specific.

• GANT61 in ALK-Positive ALCL: Cell-Cycle Evidence

  2026-10-05

  A 2026 Annals of Hematology study links GANT61-mediated Gli1 inhibition with reduced proliferation, cell-cycle arrest, apoptosis, and modulation of the PIK3IP1-Akt axis in ALK-positive anaplastic large cell lymphoma. The findings support a mechanistic model for further investigation, while remaining limited by their predominantly cellular and correlative evidence base.

• DFO Fingerprint Detection: Evidence and Limits

  2026-10-05

  DFO, or 9H-1,8-Diazafluoren-9-one, is described by APExBIO as a fluorescent reagent for amino-acid-based latent fingerprint visualization on porous materials. This overview separates supplier claims from published evidence, outlines appropriate forensic research questions, and explains why a silver-nanoparticle ferroptosis study does not validate DFO performance or safety.

• Pyridostigmine, α7 Signaling, and Placental Necroptosis

  2026-10-04

  A 2026 study connects placental ischemia, necroptosis, and non-neuronal cholinergic signaling in a rat model of preeclampsia-like disease. Its antagonist and inhibitor comparisons suggest that α7 nicotinic acetylcholine receptor activity contributes to pyridostigmine-associated reductions in placental injury, inflammation, and maternal hypertension, while leaving important questions about causality and translation unresolved.

• IR-1061: Translating NIR-II Imaging Beyond Brightness

  2026-10-03

  IR-1061 illustrates why translational NIR-II imaging depends on more than emission intensity. This thought-leadership perspective connects aggregation state, carrier architecture, biological targeting, and evidence standards while distinguishing reported findings from future research opportunities.

• PEDV Hijacks IMPDH-Dependent Nucleotide Biosynthesis

  2026-10-02

  A recent reference study shows that porcine epidemic diarrhea virus (PEDV) reprograms host purine metabolism and depends on IMPDH2-driven guanine nucleotide biosynthesis for efficient replication. By combining untargeted metabolomics, IMPDH2 knockdown, and Merimepodib (VX-497) treatment, the work identifies IMPDH as a host-directed antiviral vulnerability while highlighting strong cell-context effects.

• Entinostat: Separating Growth Arrest from Cell Death

  2026-10-01

  Entinostat and MS-275 are selective class I HDAC inhibitors with value beyond simple viability screening. This guide explains how to distinguish epigenetic growth arrest from true cancer-cell killing and design more informative translational assays.

• Z-WEHD-FMK in Caspase-1 Pyroptosis Assays

  2026-10-01

  Z-WEHD-FMK is a cell-permeable, irreversible inhibitor for interrogating inflammatory caspase activity. This article explains how to use it to distinguish caspase expression, protease activity, pyroptosis, and pathogen-driven organelle remodeling in advanced cell-based assays.

• Merimepodib (VX-497): IMPDH Assay Strategy

  2026-09-30

  Merimepodib (VX-497) offers a precise way to interrogate IMPDH-dependent guanine nucleotide metabolism. This article translates recent PEDV findings into assay-design decisions that distinguish antiviral activity, cytostasis, and target-specific nucleotide depletion.

• Targeted mRNA Nanoparticles Repair the Poststroke BBB

  2026-09-30

  The ACS Nano study developed mannose-targeted lipid nanoparticles carrying IL-10 mRNA to redirect microglia toward an anti-inflammatory state after ischemic stroke. In mouse models, this strategy reduced neuroinflammation, improved blood–brain barrier integrity, limited neuronal apoptosis, and preserved neurological function, while suggesting a therapeutic window extending to at least 72 hours.

• nor-NOHA Acetate Research Workflows

  2026-09-29

  Build reversible arginase-perturbation experiments around nor-NOHA acetate, from HepG2 apoptosis and invasion assays to endothelial signaling studies. A carefully bounded AML extension uses the compound as an arginine-metabolism probe alongside the CD36 lipid-immune framework, not as a validated AML treatment.

• EZ Cap™ Mouse CD252(OX40L) mRNA: Assay Logic

  2026-09-29

  EZ Cap™ Mouse CD252(OX40L) mRNA (m1Ψ, HA tag) enables controlled OX40L co-stimulation studies. This guide focuses on causal assay design and explains how to interpret related CD80 and 4-1BBL mRNA vaccine evidence without overextending its conclusions.

8540 records 1/570 page Next 12345 下5页 Last page